These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 53581)

  • 21. Antihypertensive effectiveness of intravenous labetalol in accelerated hypertension.
    Smith WB; Clifton GG; O'Neill WM; Wallin JD
    Hypertension; 1983; 5(4):579-83. PubMed ID: 6862581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous labetalol in the management of severe hypertension and hypertensive emergencies.
    Cressman MD; Vidt DG; Gifford RW; Moore WS; Wilson DJ
    Am Heart J; 1984 May; 107(5 Pt 1):980-5. PubMed ID: 6720529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.
    Joekes AM; Thompson FD
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):789-93. PubMed ID: 990156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Labetalol and guanfacine in the treatment of arterial hypertension in patients with chronic renal failure].
    Lifshits NL; Ermolenko VM; Rozhdestvenskaia TM; Tatsievskiĭ VA; Panasiuk VV
    Ter Arkh; 1984; 56(7):66-9. PubMed ID: 6385325
    [No Abstract]   [Full Text] [Related]  

  • 25. Labetalol in the treatment of a patient with phaechromocytoma: a case report.
    Bailey RR
    Br J Clin Pharmacol; 1979; 8(Suppl 2):141S-142S. PubMed ID: 526394
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined alpha- and beta-blockade with labetalol in post-open heart surgery hypertension. Reversal of hemodynamic deterioration with glucagon.
    Meretoja OA; Allonen H; Arola M; Laaksonen VO
    Chest; 1980 Dec; 78(6):810-5. PubMed ID: 7004797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous labetalol in hypertensive patients treated with beta-adrenoreceptor-blocking drugs.
    Pearson RM; Havard CW
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):795-8. PubMed ID: 10953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children.
    Thomas CA; Moffett BS; Wagner JL; Mott AR; Feig DI
    Pediatr Crit Care Med; 2011 Jan; 12(1):28-32. PubMed ID: 20495503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial.
    Vigil-De Gracia P; Ruiz E; López JC; de Jaramillo IA; Vega-Maleck JC; Pinzón J
    Hypertens Pregnancy; 2007; 26(2):163-71. PubMed ID: 17469006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Labetalol in the difficult hypertensive patient in general practice.
    Harris C
    Curr Med Res Opin; 1978; 5(8):618-24. PubMed ID: 710176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous labetalol is available in Australia.
    Dennis A; Walker S; Drinkwater P; Crowhurst J
    Anaesth Intensive Care; 2010 Mar; 38(2):397. PubMed ID: 20369784
    [No Abstract]   [Full Text] [Related]  

  • 33. Labetalol and pindolol in the treatment of hypertension: a comparative study.
    Romo M; Halttunen P; Saarinen P; Sarna S
    Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The electrophysiological effects of intravenous labetalol in man.
    Harley A; Coverdale HA
    Eur J Clin Pharmacol; 1981; 20(4):241-4. PubMed ID: 7308279
    [No Abstract]   [Full Text] [Related]  

  • 35. The treatment of hypertension by labetalol--a new alpha- and beta-adrenoreceptor blocking agent.
    Stern N; Teicher A; Rosenthal T
    Clin Cardiol; 1982 Feb; 5(2):125-30. PubMed ID: 7039899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy.
    Michael CA
    Aust N Z J Obstet Gynaecol; 1986 Feb; 26(1):26-9. PubMed ID: 3524548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of hypertension by labetalol (author's transl)].
    Sternon J; Melot C; Contu E
    Rev Med Brux; 1980 Nov; 1(9):615-21. PubMed ID: 7455430
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of the effects of labetalol, bendrofluazide and their combination in hypertension.
    Dawson A; Johnson BF; Smith IK; Munro-Faure AD
    Br J Clin Pharmacol; 1979 Aug; 8(2):149-54. PubMed ID: 385023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of labetalol and methyldopa in pregnancy-induced hypertension.
    Lamming GD; Symonds EB
    Br J Clin Pharmacol; 1979; 8(Suppl 2):217S-222S. PubMed ID: 526404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Labetalol: potent antihypertensive agent that blocks both alpha- and beta-adrenergic receptors.
    Milne BJ; Logan AG
    Can Med Assoc J; 1980 Nov; 123(10):1013-6. PubMed ID: 6256045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.